Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Credicorp | BAP | 18. nov 2024 | 193.15 | +0.42 |
Credit Acceptance | CACC | 18. nov 2024 | 445.96 | +0.14 |
Credit Enhanced Corts Trust Aon Capital A | KTN | 18. nov 2024 | 26.72 | -2.62 |
Credit Suisse Ag | GLDI | 18. nov 2024 | 153.55 | +2.22 |
Credit Suisse Ag | SLVO | 18. nov 2024 | 79.84 | +2.79 |
Credit Suisse Asset Management Income Fund | CIK | 18. nov 2024 | 2.95 | -1.01 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | 18. nov 2024 | 65.51 | +2.70 |
Credit Suisse High Yield Bond Fund | DHY | 18. nov 2024 | 2.18 | +0.46 |
Credo Technology | CRDO | 18. nov 2024 | 40.60 | +2.11 |
Crescent Capital BDC | CCAP | 18. nov 2024 | 19.01 | +0.16 |
Crescent Energy | CRGY | 18. nov 2024 | 14.11 | +2.54 |
Cresud A ADR | CRESY | 18. nov 2024 | 11.16 | +3.24 |
Crexendo | CXDO | 18. nov 2024 | 5.00 | +0.81 |
CRH | CRH | 18. nov 2024 | 99.65 | +1.38 |
Cricut A | CRCT | 18. nov 2024 | 5.19 | +2.77 |
Crinetics Pharmaceuticals | CRNX | 18. nov 2024 | 53.70 | -1.86 |
CRISPR Therapeutics | CRSP | 18. nov 2024 | 47.30 | +0.11 |
Criteo ADR | CRTO | 18. nov 2024 | 36.54 | -1.04 |
Critical Metals | CRML | 18. nov 2024 | 5.91 | +0.17 |
Crocs | CROX | 18. nov 2024 | 96.51 | -1.30 |
Cronos Group | CRON | 18. nov 2024 | 2.04 | +1.49 |
Cross Country Healthcare | CCRN | 18. nov 2024 | 10.34 | +5.40 |
Cross Timbers Royalty Royalty Trust | CRT | 18. nov 2024 | 10.15 | +2.32 |
CrossAmerica Partners LP Unit | CAPL | 18. nov 2024 | 20.00 | -0.74 |
CrossFirst Bankshares | CFB | 18. nov 2024 | 17.09 | -0.23 |
CrowdStrike A | CRWD | 18. nov 2024 | 342.97 | +1.85 |
Crown Castle | CCI | 18. nov 2024 | 104.59 | +0.76 |
Crown Crafts | CRWS | 18. nov 2024 | 4.43 | -2.32 |
Crown ElectroKinetics | CRKN | 18. nov 2024 | 0.85 | -3.85 |
Crown Holdings | CCK | 18. nov 2024 | 89.38 | -0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.